• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Numeta G13E与新生儿重症监护常用药物的Y位物理相容性

Y-Site Physical Compatibility of Numeta G13E with Drugs Frequently Used at Neonatal Intensive Care.

作者信息

Nezvalova-Henriksen Katerina, Nilsson Niklas, Østerberg Camilla Tomine, Staven Berge Vigdis, Tho Ingunn

机构信息

Oslo Hospital Pharmacy, Rikshospitalet/Ullevål, Hospital Pharmacy Enterprise, South Eastern Norway, 0050 Oslo, Norway.

Department of Pharmacy, University of Oslo, 0316 Oslo, Norway.

出版信息

Pharmaceutics. 2020 Jul 18;12(7):677. doi: 10.3390/pharmaceutics12070677.

DOI:10.3390/pharmaceutics12070677
PMID:32708409
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7408039/
Abstract

Preterm neonates require parenteral nutrition (PN) in addition to intravenous drug therapy. Due to limited venous access, drugs are often co-administered with PN via the same lumen. If incompatible, precipitation and emulsion destabilization may occur with the consequent risk of embolism and hyper-immune reactions. Information on intravenous compatibility is scarce. Our aim was to analyse the compatibility of Numeta G13E with paracetamol, vancomycin and fentanyl because of the frequency of their use. A panel of methods was chosen to assess precipitation (sub-visual particle counting, turbidity measurement, Tyndall beam effect and pH measurement) and emulsion destabilization (mean droplet diameter measurement and sub-visual counting of oil droplets, followed by estimation of PFAT5 (percentage of fat residing in globules larger than 5 µm) and pH measurement). Samples in clinically relevant mixing ratios were tested immediately and after 4 h. All samples of drugs mixed with Numeta G13E were compared to unmixed controls. None of the tested drugs precipitated in contact with Numeta G13E, and we did not see any sign of emulsion destabilization when clinically relevant mixing ratios were applied. These results are reassuring. However, when contact time exceeds the established norm, caution in the form of filter utilisation and close inspection is advised.

摘要

除静脉药物治疗外,早产儿还需要肠外营养(PN)。由于静脉通路有限,药物通常通过同一管腔与PN联合给药。如果不相容,可能会发生沉淀和乳剂不稳定,从而有栓塞和超敏反应的风险。关于静脉相容性的信息很少。由于使用频率较高,我们的目的是分析Numeta G13E与对乙酰氨基酚、万古霉素和芬太尼的相容性。选择了一组方法来评估沉淀(亚视觉颗粒计数、浊度测量、廷德尔光束效应和pH测量)和乳剂不稳定(平均液滴直径测量和油滴亚视觉计数,随后估计PFAT5(大于5 µm的球粒中脂肪的百分比)和pH测量)。以临床相关混合比例的样品立即和4小时后进行测试。将所有与Numeta G13E混合的药物样品与未混合的对照进行比较。与Numeta G13E接触的受试药物均未沉淀,当采用临床相关混合比例时,我们未观察到任何乳剂不稳定的迹象。这些结果令人放心。然而,当接触时间超过既定标准时,建议使用过滤器并仔细检查。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/565a/7408039/4e9f0dac1285/pharmaceutics-12-00677-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/565a/7408039/4e9f0dac1285/pharmaceutics-12-00677-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/565a/7408039/4e9f0dac1285/pharmaceutics-12-00677-g001.jpg

相似文献

1
Y-Site Physical Compatibility of Numeta G13E with Drugs Frequently Used at Neonatal Intensive Care.Numeta G13E与新生儿重症监护常用药物的Y位物理相容性
Pharmaceutics. 2020 Jul 18;12(7):677. doi: 10.3390/pharmaceutics12070677.
2
Co-administration of drugs with parenteral nutrition in the neonatal intensive care unit-physical compatibility between three components.新生儿重症监护病房中肠外营养与药物同时使用-三种成分的物理相容性
Eur J Pediatr. 2022 Jul;181(7):2685-2693. doi: 10.1007/s00431-022-04466-z. Epub 2022 Apr 14.
3
Physical compatibility of total parenteral nutrition and drugs in Y-site administration to children from neonates to adolescents.新生儿至青少年儿童经Y型接口肠外营养与药物的物理相容性
J Pharm Pharmacol. 2017 Apr;69(4):448-462. doi: 10.1111/jphp.12647. Epub 2016 Oct 7.
4
Development and evaluation of a test program for Y-site compatibility testing of total parenteral nutrition and intravenous drugs.全胃肠外营养与静脉用药 Y 型接口兼容性测试程序的开发与评估
Nutr J. 2016 Mar 22;15:29. doi: 10.1186/s12937-016-0149-x.
5
Potential Use of Common Administration of Emulsion for Parenteral Nutrition and Vinpocetine: Compatibility Study and Prospect.肠外营养乳剂与长春西汀联合应用的可能性:配伍研究与展望
Metabolites. 2024 Aug 7;14(8):439. doi: 10.3390/metabo14080439.
6
In vitro compatibility studies of vancomycin with ready-to-use parenteral nutrition admixtures for safer clinical practice.万古霉素与即用型肠外营养添加剂的体外相容性研究,以确保更安全的临床实践。
Clin Nutr. 2020 Aug;39(8):2539-2546. doi: 10.1016/j.clnu.2019.11.014. Epub 2019 Nov 15.
7
Physical stability of an all-in-one parenteral nutrition admixture for preterm infants upon mixing with micronutrients and drugs.全合一型早产儿肠外营养混合液与微量营养素和药物混合后的物理稳定性。
Eur J Hosp Pharm. 2020 Jan;27(1):36-42. doi: 10.1136/ejhpharm-2018-001562. Epub 2018 Jul 7.
8
The Interactions between Ciprofloxacin and Parenteral Nutrition Admixtures.环丙沙星与肠外营养混合液之间的相互作用。
Pharmaceutics. 2019 Dec 27;12(1):27. doi: 10.3390/pharmaceutics12010027.
9
Physicochemical Stability and Sterility of Standard Parenteral Nutrition Solutions and Simulated Y-Site Admixtures for Neonates.新生儿标准肠外营养液和模拟 Y 型管混合液的理化稳定性和无菌性。
Nutr Clin Pract. 2018 Oct;33(5):694-700. doi: 10.1002/ncp.10013. Epub 2018 Feb 21.
10
Co-Administration of Drugs and Parenteral Nutrition: In Vitro Compatibility Studies of Loop Diuretics for Safer Clinical Practice.药物与肠外营养的联合应用:襻利尿剂的体外相容性研究以实现更安全的临床实践
Pharmaceutics. 2020 Nov 13;12(11):1092. doi: 10.3390/pharmaceutics12111092.

引用本文的文献

1
Y-Site Compatibility Studies of Parenteral Nutrition and Other Intravenous Medications in Neonatal and Pediatric Patients: A Review of the Literature Evidence.新生儿和儿科患者肠外营养与其他静脉用药的Y型接口兼容性研究:文献证据综述
Pharmaceutics. 2024 Feb 12;16(2):264. doi: 10.3390/pharmaceutics16020264.
2
Y-Site Compatibility Studies of Ketoprofen with Parenteral Nutrition Admixtures for Central and Peripheral Administration.酮洛芬与用于中心和外周给药的肠外营养混合液的Y型接口相容性研究。
Pharmaceutics. 2022 Nov 23;14(12):2570. doi: 10.3390/pharmaceutics14122570.
3
Exploring a case of incompatibility in a complex regimen containing Plasma-Lyte 148 in the pediatric intensive care.

本文引用的文献

1
Physical stability of an all-in-one parenteral nutrition admixture for preterm infants upon mixing with micronutrients and drugs.全合一型早产儿肠外营养混合液与微量营养素和药物混合后的物理稳定性。
Eur J Hosp Pharm. 2020 Jan;27(1):36-42. doi: 10.1136/ejhpharm-2018-001562. Epub 2018 Jul 7.
2
Investigations of Physical Compatibilities of Commonly Used Intravenous Medications with and without Parenteral Nutrition in Pediatric Cardiovascular Intensive Care Unit Patients.儿科心血管重症监护病房患者常用静脉药物与有无肠外营养的物理相容性研究。
Pharmaceuticals (Basel). 2019 May 4;12(2):67. doi: 10.3390/ph12020067.
3
探讨儿科重症监护中含有 Plasma-Lyte 148 的复杂治疗方案中的不相容性案例。
Paediatr Anaesth. 2023 Mar;33(3):211-218. doi: 10.1111/pan.14598. Epub 2022 Nov 21.
4
Frequently acquired drugs in neonatal intensive care and their physical compatibility. 新生儿重症监护室中常使用的药物及其物理相容性。
Acta Paediatr. 2022 Dec;111(12):2307-2314. doi: 10.1111/apa.16526. Epub 2022 Aug 30.
5
Co-administration of drugs with parenteral nutrition in the neonatal intensive care unit-physical compatibility between three components.新生儿重症监护病房中肠外营养与药物同时使用-三种成分的物理相容性
Eur J Pediatr. 2022 Jul;181(7):2685-2693. doi: 10.1007/s00431-022-04466-z. Epub 2022 Apr 14.
ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: Energy.
欧洲儿科胃肠病、肝病和营养学会/欧洲临床营养与代谢学会/欧洲儿科研究学会/欧洲临床营养与代谢学会儿科肠外营养指南:能量
Clin Nutr. 2018 Dec;37(6 Pt B):2309-2314. doi: 10.1016/j.clnu.2018.06.944. Epub 2018 Jun 18.
4
ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: Venous access.欧洲儿科胃肠病、肝病和营养学会/欧洲临床营养和代谢学会/欧洲儿科研究学会/临床营养支持学会关于儿科肠外营养的指南:静脉通路
Clin Nutr. 2018 Dec;37(6 Pt B):2379-2391. doi: 10.1016/j.clnu.2018.06.952. Epub 2018 Jun 18.
5
Clinical implications of intravenous drug incompatibilities in critically ill patients.危重症患者静脉药物不相容的临床意义。
Anaesth Crit Care Pain Med. 2019 Apr;38(2):173-180. doi: 10.1016/j.accpm.2018.04.003. Epub 2018 Apr 19.
6
Physical compatibility of total parenteral nutrition and drugs in Y-site administration to children from neonates to adolescents.新生儿至青少年儿童经Y型接口肠外营养与药物的物理相容性
J Pharm Pharmacol. 2017 Apr;69(4):448-462. doi: 10.1111/jphp.12647. Epub 2016 Oct 7.
7
Development and evaluation of a test program for Y-site compatibility testing of total parenteral nutrition and intravenous drugs.全胃肠外营养与静脉用药 Y 型接口兼容性测试程序的开发与评估
Nutr J. 2016 Mar 22;15:29. doi: 10.1186/s12937-016-0149-x.
8
Utilization of the tyndall effect for enhanced visual detection of particles in compatibility testing of intravenous fluids: validity and reliability.在静脉输液相容性测试中利用廷德尔效应增强颗粒的视觉检测:有效性和可靠性
PDA J Pharm Sci Technol. 2015 Mar-Apr;69(2):270-83. doi: 10.5731/pdajpst.2015.01020.
9
Physical compatibility of various drugs with neonatal total parenteral nutrient solution during simulated Y-site administration.模拟 Y 型部位给药时,各种药物与新生儿全胃肠外营养液的物理相容性。
Am J Health Syst Pharm. 2013 Mar 15;70(6):520-4. doi: 10.2146/ajhp110715.
10
Early parenteral nutrition and growth outcomes in preterm infants: a systematic review and meta-analysis.早产儿早期肠外营养与生长结局:系统评价和荟萃分析。
Am J Clin Nutr. 2013 Apr;97(4):816-26. doi: 10.3945/ajcn.112.042028. Epub 2013 Feb 27.